4.5 Review

A systemic review of T-cell epitopes defined from the proteome of SARS-CoV-2

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron

Alison Tarke et al.

Summary: T cell responses induced by different vaccine platforms cross-recognize early SARS-CoV-2 variants, while memory B cells and neutralizing antibodies show significant decreases. The majority of memory T cell responses are preserved against variants, with lower recognition of Omicron by memory B cells.
Article Immunology

One-Year Sustained Cellular and Humoral Immunities in Coronavirus Disease 2019 (COVID-19) Convalescents

Jie Zhang et al.

Summary: The study found that the SARS-CoV-2-specific cellular and humoral immunities in COVID-19 convalescents are durable for at least one year after disease onset. This is crucial for long-term protection upon re-exposure to the virus and achieving population-level immunity.

CLINICAL INFECTIOUS DISEASES (2022)

Article Biotechnology & Applied Microbiology

Selection and T-cell antigenicity of synthetic long peptides derived from SARS-CoV-2

Katarzyna Piadel et al.

Summary: The study investigates alternative vaccine strategies to broaden T-cell responses and provide cross-immunity against SARS-CoV-2 variants and future coronavirus outbreaks. Highly conserved peptides containing immunogenic epitopes were synthesized and demonstrated antigenicity against T-cells from individuals with previous SARS-CoV-2 infection.

JOURNAL OF GENERAL VIROLOGY (2022)

Article Multidisciplinary Sciences

Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2

Leo Swadling et al.

Summary: Research suggests that some individuals can clear potential SARS-CoV-2 infection after exposure, with T cells playing a role in the process. Studying healthcare workers who tested negative for antibodies revealed that they had stronger and more diverse memory T cells, with a focus on RTC.

NATURE (2022)

Article Multidisciplinary Sciences

Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors

Daichao Wu et al.

Summary: This study reveals the structural information of SARS-CoV-2-specific T-cell receptors (TCRs) bound to their peptide-MHC targets and explains the mechanisms behind their selection of specific germline genes and recognition of different variants. This has important implications for designing vaccines to elicit pan-coronavirus immunity.

NATURE COMMUNICATIONS (2022)

Article Cell Biology

Recruitment of highly cytotoxic CD8+ T cell in mild SARS-CoV-2 infection

Karolin I. Wagner et al.

Summary: This study isolated TCR repertoires specific for SARS-CoV-2 epitopes restricted to common HLA class I molecules in convalescent individuals. SARS-CoV-2-specific CD8(+) T cells were found to be detectable up to 12 months after infection. The TCR repertoires were diverse, with heterogeneous functional avidity and cytotoxicity towards virus-infected cells.

CELL REPORTS (2022)

Article Biochemistry & Molecular Biology

Recurrence of COVID-19 associated with reduced T-cell responses in a monozygotic twin pair

Mateus de Castro et al.

Summary: The recurrence of COVID-19 in recovered patients has become increasingly common. This study investigated the immune mechanisms behind the recurrence and found that a lack of a broad T-cell response to the initial infection may have led to the recurrence. This emphasizes the importance of an effective SARS-CoV-2-specific T-cell immune response in controlling the virus and preventing clinical recurrence of COVID-19.

OPEN BIOLOGY (2022)

Article Microbiology

SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variants

Archana Panikkar et al.

Summary: Adoptive T-cell immunotherapy has shown promising results in treating viral complications, especially in immunocompromised patients. Expanding T cells from healthy individuals provides a new approach to antiviral immunotherapy with rapid and customized treatment options. Recent research indicates that SARS-CoV-2-specific T cells play a crucial role in protecting against COVID-19, suggesting the potential of using HLA-matched virus-specific T cells for treating active COVID-19 or at-risk patients.

PLOS PATHOGENS (2022)

Article Immunology

Identification of a promiscuous conserved CTL epitope within the SARS-CoV-2 spike protein

Sheng Jiang et al.

Summary: This study predicted T cell epitopes of SARS-CoV-2 and identified a CTL epitope suitable for future COVID-19 vaccine candidates.

EMERGING MICROBES & INFECTIONS (2022)

Article Microbiology

Limited Recognition of Highly Conserved Regions of SARS-CoV-2

Srividhya Swaminathan et al.

Microbiology Spectrum (2022)

Article Multidisciplinary Sciences

SARS-CoV-2 variant B.1.1.7 caused HLA-A2+ CD8+ T cell epitope mutations for impaired cellular immune response

Chanchan Xiao et al.

Summary: This study evaluated the immune properties of CD8(+) T cell epitopes containing mutations from the B.1.1.7 variant and analyzed the CD8(+) T cell responses in COVID-19 convalescent patients and SARS-CoV-2 vaccinees. The results showed that mutations in B.1.1.7 led to a decrease in CD8(+) T cell activation and a possible immune evasion.

ISCIENCE (2022)

Article Immunology

SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8+ T cells

Anastasia A. Minervina et al.

Summary: Thomas and colleagues explore the impact of multiple SARS-CoV-2 antigen exposures on T cell immunity. They find that vaccination after infection leads to expansion of spike-specific T cells, while individuals after breakthrough infection mount vigorous non-spike-specific responses. They also observe that all exposures elicit diverse T cell immune repertoires, with no evidence of repertoire narrowing from repeated exposure.

NATURE IMMUNOLOGY (2022)

Article Medicine, General & Internal

Enzyme-Linked Immunosorbent Assay: An Adaptable Methodology to Study SARS-CoV-2 Humoral and Cellular Immune Responses

Amanda Izeli Portilho et al.

Summary: The Enzyme-Linked Immunosorbent Assay (ELISA) is a versatile technique that has made significant contributions to infectious disease research. This review highlights its application in the study of COVID-19, allowing scientists to gain a better understanding of the immune response against SARS-CoV-2. ELISA can be modified to assess antibody functionality and study cellular immunity, providing valuable insights into the differences between natural and vaccine-induced immune responses.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Medicine, Research & Experimental

Immunogenic epitope panel for accurate detection of non-cross-reactive T cell response to SARS-CoV-2

Aleksei Titov et al.

Summary: This study evaluated T cell immune responses in vaccinated, convalescent, unexposed, and SARS-CoV-2-exposed individuals, identified multiple immunogenic epitopes, and discovered the presence of cross-reactive epitopes. The study also developed an in vitro diagnostic test using these epitopes, which showed high accuracy. For some asymptomatic seronegative individuals, a complete absence of T cell response to these immunogenic epitopes suggests a potential protective role of cross-reactive immune response.

JCI INSIGHT (2022)

Article Medicine, Research & Experimental

CD4+ T cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses

Bezawit A. Woldemeskel et al.

Summary: Recent studies have found that vaccinated individuals possess T cells that can recognize both SARS-CoV-2 and common cold coronaviruses. This study identified a conserved epitope (S815-827) in the spike protein of SARS-CoV-2, which is also present in other coronaviruses including those from bats. The researchers found that 42% of vaccinated participants recognized this epitope and that CD4(+) T cells from responders could cross-recognize similar peptides from other coronaviruses. This suggests that the current mRNA vaccines may provide some protection against future zoonotic outbreaks and informs the development of pan-coronavirus vaccine strategies.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Article Public, Environmental & Occupational Health

A COVID-19 T-Cell Response Detection Method Based on a Newly Identified Human CD8+ T Cell Epitope from SARS-CoV-2-Hubei Province, China, 2021

Jie Zhangl et al.

Summary: This study identified a newly derived T-cell epitope from SARS-CoV-2, which could be helpful in detecting cellular immunity against different sarbecoviruses. It also provided an evaluation method and peptide candidate for the research and development of T-cell based vaccine for the virus.

CHINA CDC WEEKLY (2022)

Article Biochemistry & Molecular Biology

Identification of cross-reactive CD8+ T cell receptors with high functional avidity to a SARS-CoV-2 immunodominant epitope and its natural mutant variants

Chao Hu et al.

Summary: This study identified specific CD8(+) T cell responses in over 75% of COVID-19 convalescent patients, with the N361-369 epitope from the N protein being the most dominant. Two N361-369-specific TCRs may offer functional superiority in cellular immunity against SARS-CoV-2.

GENES & DISEASES (2022)

Review Immunology

T-cell responses and therapies against SARS-CoV-2 infection

Salman M. Toor et al.

Summary: COVID-19 is potentially an immune-related disease, where T cells play a crucial role with both pro- and anti-functions. Understanding the role of T cells in immune responses is essential for better management of COVID-19.

IMMUNOLOGY (2021)

Article Immunology

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

Annika Nelde et al.

Summary: SARS-CoV-2-specific T cell epitopes were identified in convalescent and unexposed individuals, showing cross-reactivity with common cold coronaviruses. The diversity of SARS-CoV-2 T cell responses may be associated with mild symptoms of COVID-19.

NATURE IMMUNOLOGY (2021)

Article Immunology

Screening HLA-A-restricted T cell epitopes of SARS-CoV-2 and the induction of CD8+ T cell responses in HLA-A transgenic mice

Xiaoxiao Jin et al.

Summary: This study validated multiple T cell epitopes related to SARS-CoV-2 and developed vaccines that induce specific T cell responses. Utilizing different combination strategies and immunogens, the vaccines successfully elicited robust and specific CD8(+) T cell responses.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Article Cell Biology

T and B cell Epitope analysis of SARS-CoV-2 S protein based on immunoinformatics and experimental research

Ziwei Chen et al.

Summary: This study identified potential B and T cell epitopes from the S protein of SARS-CoV-2 using immunoinformatics, highlighting specific peptide epitopes with high antigenicity and immunogenicity for vaccine development. The study also showed stable interactions between the predicted peptide epitopes and HLA, suggesting their efficacy as novel vaccine targets to prevent SARS-CoV-2 infection.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Immunology

A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4+ and CD8+ T Cells in COVID-19 Patients

Henning Zelba et al.

Summary: This study adapted a protocol for the detection of cellular immune responses against SARS-CoV-2 and successfully detected SARS-CoV-2-specific T cells in all COVID-19 patients, but not in unexposed healthy individuals.

JOURNAL OF IMMUNOLOGY (2021)

Article Virology

Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity

Eunok Lee et al.

Summary: Developing optimal T-cell response assays for SARS-CoV-2 is crucial for measuring immunity duration and vaccine efficacy. By using immunoinformatics analysis, we identified 57 immunogenic peptides with potential global cellular immune response coverage. 18 of these peptides have limited homology to seasonal human coronaviruses, making them promising candidates for specific T-cell immunity tests for SARS-CoV-2. Two peptides elicited effector responses in CD8+ T cells from SARS-CoV-2 convalescent patients.

JOURNAL OF VIROLOGY (2021)

Article Multidisciplinary Sciences

The presentation of SARS-CoV-2 peptides by the common HLA-A*02:01 molecule

Christopher Szeto et al.

Summary: Not all peptides derived from the internal SARS-CoV-2 nucleocapsid protein can form a complex with HLA-A*02:01, and some peptides adopt a mobile conformation. Limited pre-existing CD8+ T cell response toward these epitopes is observed in unexposed individuals.

ISCIENCE (2021)

Article Medicine, Research & Experimental

SARS-CoV-2 specific CD8+ T cell responses in convalescent COVID-19 individuals

Hassen Kared et al.

Summary: Characterization of T cell responses in convalescent individuals from SARS-CoV-2 infection revealed unique phenotypes and a coordinated immune response, with specific CD8(+) T cell responses directed against various epitopes from the virus proteome. The differentiation of T cells into stem cell and transitional memory subsets may be crucial for developing lasting protection against the virus.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Immunology

Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection

Nina Le Bert et al.

Summary: The efficacy of virus-specific T cells in clearing pathogens involves a delicate balance between antiviral and inflammatory responses. Asymptomatic individuals clearing SARS-CoV-2 showed increased production of IFN-gamma and IL-2, along with a proportional secretion of IL-10 and proinflammatory cytokines, while symptomatic individuals displayed a disproportionate secretion of inflammatory cytokines triggered by SARS-CoV-2-specific T cell activation.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Article Multidisciplinary Sciences

Mass spectrometric identification of immunogenic SARS-CoV-2 epitopes and cognate TCRs

Ke Pan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Immunology

Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection

Jianmin Zuo et al.

Summary: The study shows that functional SARS-CoV-2-specific T cell responses are retained and robust at 6 months following infection, with higher T cell responses observed in donors who had experienced symptomatic infection. Levels of nucleoprotein-specific T cells were correlated with nucleoprotein-specific antibody levels, providing insights into the persistence and correlation of immune responses.

NATURE IMMUNOLOGY (2021)

Article Immunology

Assessment of SARS-CoV-2 specific CD4(+) and CD8 (+) T cell responses using MHC class I and II tetramers

Yuri Poluektov et al.

Summary: The study focuses on evaluating the binding affinities of SARS-CoV-2 peptides to different MHC alleles using the QuickSwitchTM platform, identifying multiple MHC binders with high promiscuity. These results provide important data for further research on the SARS-CoV-2 virus and its antigenic epitopes.

VACCINE (2021)

Article Virology

SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects

Juan Zhao et al.

Summary: Research shows that COVID-19-recovered individuals exhibit specific T cell responses, potentially offering protection against reinfection for some exposed individuals and inducing protective immunity in unexposed individuals upon vaccination. There is a need for a multi-epitope strategy in COVID-19 vaccine design due to the low immunogenicity of SARS-CoV-2 S and N peptides at inducing robust T cell responses.

VIRUS RESEARCH (2021)

Article Immunology

SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8(+) T cell responses

Benedikt Agerer et al.

Summary: The study identified nonsynonymous mutations in MHC-I-restricted CD8(+) T cell epitopes of SARS-CoV-2 virus isolates, which resulted in diminished MHC-I binding of mutant peptides. This led to decreased proliferation, IFN-gamma production, and cytotoxic activity of CD8(+) T cells, along with qualitative differences in the transcriptional response to mutant peptides. These findings highlight the ability of SARS-CoV-2 to evade CD8(+) T cell surveillance through point mutations in MHC-I-restricted viral epitopes.

SCIENCE IMMUNOLOGY (2021)

Article Microbiology

Cross-reactive and mono-reactive SARS-CoV-2 CD4+T cells in prepandemic and COVID-19 convalescent individuals

Alexandra M. Johansson et al.

Summary: This study identified SARS-CoV-2 CD4+ T cell epitopes using tetramer reagents, distinguishing immunodominant and subdominant epitopes. Among the four potential Spike-specific cross-reactive epitopes identified, three were subdominant epitopes, while only one was an immunodominant epitope.

PLOS PATHOGENS (2021)

Article Microbiology

Peptides Derived From S and N Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Induce T Cell Responses: A Proof of Concept for T Cell Vaccines

Yu-Sun Lee et al.

Summary: This study demonstrates the importance of T cell responses against SARS-CoV-2 and the potential of peptide vaccines to induce protective immune responses. Immunization with these peptides increases effector memory T cells and IFN-gamma, IL-4, TNF-alpha, and granzyme B-producing T cells, while some peptides induce IFN-gamma-producing T cells and CTL responses, leading to cytotoxic T lymphocytes that eliminate target cells. Peptide vaccines also show promise in reducing viral titers and alleviating pulmonary pathology in animal models of SARS-CoV-2 infection.

FRONTIERS IN MICROBIOLOGY (2021)

Article Immunology

CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses

Katie E. Lineburg et al.

Summary: Efforts are being made to understand the immune response to SARS-CoV-2, with a focus on T cell immunity and cross-recognition with seasonal coronaviruses. Research has shown that the N protein of SARS-CoV-2 induces an immunodominant response and T cells demonstrate cross-reactivity towards certain coronaviruses through specific peptide conformations.

IMMUNITY (2021)

Article Medicine, General & Internal

Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naive CD8 T cells of unexposed individuals

Isaac Quiros-Fernandez et al.

Summary: Recent studies have shown evidence of cross-reactive CD8 T cells in non-exposed individuals to SARS-CoV-2, which can stabilize HLA molecules and activate CD8 T cells in healthy unexposed subjects. The reactive cells were found in naive, memory, and effector subsets, indicating a diverse T cell response in individuals without previous exposure to the virus.

EBIOMEDICINE (2021)

Article Immunology

Genome-Wide B Cell, CD4+, and CD8+ T Cell Epitopes That Are Highly Conserved between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Targets for Preemptive Pan-Coronavirus Vaccines

Swayam Prakash et al.

Summary: The study identified several conserved human B cell and T cell epitopes across different coronaviruses, suggesting potential for developing a pan-coronavirus vaccine; these epitopes triggered immune responses in both COVID-19 patients and individuals never exposed to SARS-CoV-2, as well as in double-transgenic mice; paving the way for a preemptive multiepitope pancoronavirus vaccine to protect against past, current, and future outbreaks.

JOURNAL OF IMMUNOLOGY (2021)

Article Biology

Identification of TCR repertoires in functionally competent cytotoxic T cells cross-reactive to SARS-CoV-2

Kanako Shimizu et al.

Summary: Identification of immunodominant epitopes in the SARS-CoV-2 spike region provides insight into cross-reactivity of CD8(+) T cells. Cross-reactive CD8(+) T cells are reduced in immunosuppressed patients with hematological malignancy. T-cell receptors isolated from selective pre-existing CD8(+) T cells exhibit diverse cross-reactivity at the single-cell level.

COMMUNICATIONS BIOLOGY (2021)

Article Multidisciplinary Sciences

Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2

Jun Siong Low et al.

Summary: The study demonstrates a robust CD4(+) T cell response to SARS-CoV-2 spike and nucleoprotein in COVID-19-recovered individuals, with a highly immunogenic receptor-binding domain (RBD). Through characterizing T cell clones, it was found that a region containing nested HLA-DR and HLA-DP-restricted epitopes is immunodominant. Cross-reactive T cells targeting multiple S protein sites were identified, which can guide vaccination strategies against emerging SARS-CoV-2 variants.

SCIENCE (2021)

Article Multidisciplinary Sciences

Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features

Anastasia Gangaev et al.

Summary: This study identified a range of SARS-CoV-2 CD8(+) T cell responses across COVID-19 patients, including an epitope from ORF1ab with immunodominant features. The specific CD8(+) T cell responses can still be detectable up to 5 months after recovery from critical and severe disease, converting from dysfunctional effector cells to functional memory cells during convalescence.

NATURE COMMUNICATIONS (2021)

Article Immunology

SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses

Katja G. Schmidt et al.

Summary: Research suggests that cross-reactive T-cell responses to SARS-CoV-2 may influence the severity of infection in certain populations. In HIV-1 patients, approximately 37.9% showed T-cell reactivity to SARS-CoV-2, potentially impacting the development of severe COVID-19.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation

Lauren M. Meyers et al.

Summary: This study identified peptide epitopes associated with SARS-CoV-2 T-cell immunity and demonstrated epitope-specific T-cell responses through direct restimulation and T-cell expansion. Immunization of HLA-DR3 transgenic mice generated a potent Th1-skewed, epitope-specific memory response, offering a potential approach for developing T-cell-targeted vaccines.

NPJ VACCINES (2021)

Article Immunology

SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients

Sunil Kumar Saini et al.

Summary: This study experimentally evaluated MHC class I-binding peptides covering the complete SARS-CoV-2 genome, revealing significant CD8(+) T cell recognition of SARS-CoV-2 epitopes in patients with COVID-19, coupled with strong activation features in these T cells. Compared to healthy individuals, patients with severe disease displayed larger populations of SARS-CoV-2-specific T cells.

SCIENCE IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs

Shira Weingarten-Gabbay et al.

Summary: T cell-mediated immunity plays a crucial role in controlling SARS-CoV-2 infection, with some peptides derived from internal out-of-frame ORFs in spike and nucleocapsid eliciting stronger T cell responses than canonical peptides. Early expressed viral proteins contribute more to HLA-I presentation and immunogenicity, providing insights for vaccine development and immune monitoring.
Article Immunology

Human CD4+ T cells specific for dominant epitopes of SARS-CoV-2 Spike and Nucleocapsid proteins with therapeutic potential

Johan Verhagen et al.

Summary: Since December 2019, the rapid spread of COVID-19 has prompted a global effort to develop vaccines and treatments. T cell therapy may enhance the efficacy of current treatments by targeting specific antigens of the virus. Identifying T cells with potentially protective responses against key SARS-CoV-2 antigens is a crucial step towards TCR-transgenic CD4(+) T cell therapy for COVID-19.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2021)

Article Cell Biology

SARS-CoV-2-specific CD8+ T-cell responses and TCR signatures in the context of a prominent HLA-A*24:02 allomorph

Louise C. Rowntree et al.

Summary: This study identified novel HLA-A*24:02-restricted epitopes of SARS-CoV-2 and characterized the CD8(+) T-cell responses associated with this HLA allomorph during COVID-19. The frequencies of A24/SARS-CoV-2-specific CD8(+) T cells increased substantially during COVID-19, showing effector and memory phenotypes. Ex vivo analyses of TCR alpha beta repertoires revealed distinct differences in repertoire diversity among COVID-19 patients for different epitopes.

IMMUNOLOGY AND CELL BIOLOGY (2021)

Article Biochemistry & Molecular Biology

Structural basis of biased T cell receptor recognition of an immunodominant HLA-A2 epitope of the SARS-CoV-2 spike protein

Priyanka Chaurasia et al.

Summary: CD8(+) T cells are crucial in immunity against SARS-CoV-2 infection, with the HLA-A2S(269-277) epitope being the most immunodominant. Studies show that TRAV12(+) T cell receptors are sensitive to sequence variation within the S269-277 peptide. However, the TRAV12(+) T cell repertoire demonstrates poor cross-reactivity with analogous epitopes from SARS-CoV-2 variants and related coronaviruses.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Article Immunology

Large-Scale Identification of T-Cell Epitopes Derived From Severe Acute Respiratory Syndrome Coronavirus 2 for the Development of Peptide Vaccines Against Coronavirus Disease 2019

Yipeng Ma et al.

Summary: The study identified 7 epitopes derived from 4 SARS-CoV-2 proteins, with most peptides being HLA-II-restricted and inducing CD4 + T cell-dependent responses. These findings suggest the presence of pre-existing T cells targeting all SARS-CoV-2-encoded proteins in unexposed populations.

JOURNAL OF INFECTIOUS DISEASES (2021)

Article Cell Biology

Identification of HLA-A2 restricted CD8+ T cell epitopes in SARS-CoV-2 structural proteins

Jieping Deng et al.

Summary: This study identified specific CD8(+) T cell epitopes in the structural proteins of SARS-CoV-2, which effectively activated and induced the production of specific immune competent CD8(+) T cells by predicting specific epitopes and exploring their immunogenic properties.

JOURNAL OF LEUKOCYTE BIOLOGY (2021)

Article Multidisciplinary Sciences

Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine

Valerie Oberhardt et al.

Summary: After vaccination, CD8(+) T cells become important effector cells in providing early protection, being effectively mobilized one week after primary vaccination and maintaining stability after booster vaccination. Compared with natural infection, vaccine-induced CD8(+) T cells exhibit similar functional capacities but with a different subset distribution.

NATURE (2021)

Article Multidisciplinary Sciences

Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination

Lucie Loyal et al.

Summary: The study demonstrates that preexisting spike-cross-reactive T cells play a functional role in the immune response to SARS-CoV-2 infection and vaccination. Cross-reactive immunity may explain the rapid induction of immunity after primary SARS-CoV-2 immunization and the high rate of asymptomatic or mild COVID-19 cases.

SCIENCE (2021)

Article Multidisciplinary Sciences

Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals

Swapnil Mahajan et al.

Summary: The study identified immunodominant CD8 T-cell epitopes in the spike antigen of SARS-CoV-2, which induced robust T-cell activation in unexposed donors. Pre-existing T-cell immunity to SARS-CoV-2 is likely contributed by TCRs recognizing common viral antigens such as Influenza and CMV rather than shared epitopes with other coronaviruses.

SCIENTIFIC REPORTS (2021)

Article Cell Biology

Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics

Adi Nagler et al.

Summary: This study identified SARS-CoV-2-derived peptides presented by HLA-I and HLA-II molecules, some of which are immunogenic, potentially aiding in the development of next-generation SARS-CoV-2 vaccines.

CELL REPORTS (2021)

Article Cell Biology

Profiling CD8+ T cell epitopes of COVID-19 convalescents reveals reduced cellular immune responses to SARS-CoV-2 variants

Hang Zhang et al.

Summary: Cellular immunity plays a crucial role in determining the disease severity of COVID-19 patients. Identified epitopes from SARS-CoV-2 are conserved across human coronaviruses, suggesting a potential pre-existing cellular immunity. Mutations in newly circulating variants reduce T cell responses to epitopes, indicating a possible evasion of cellular immunity.

CELL REPORTS (2021)

Article Microbiology

Broadly directed SARS-CoV-2-specific CD4+T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19

Janna Heide et al.

Summary: The study aimed to explore the CD4+ T cell response to SARS-CoV-2 and found a universally broad T cell response in patients, identifying multiple specific peptides. These findings are important for understanding the immunopathogenesis of SARS-CoV-2 infection and vaccine design.

PLOS PATHOGENS (2021)

Article Immunology

BCG Vaccine Derived Peptides Induce SARS-CoV-2 T Cell Cross-Reactivity

Peter J. Eggenhuizen et al.

Summary: The Bacillus Calmette-Guerin (BCG) vaccine can enhance T cell response to the SARS-CoV-2 virus, providing a potential mechanism for the observed protective effects against COVID-19.

FRONTIERS IN IMMUNOLOGY (2021)

Article Genetics & Heredity

A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent Subjects

Eszter Somogyi et al.

Summary: Long-term immunity to coronaviruses is likely T cell-based. A novel approach was presented to select immunoprevalent SARS-CoV-2 T cell epitopes, leading to the development of a peptide vaccine candidate. Results showed robust multi-antigenic T cell responses induced by PolyPEPI-SCoV-2 vaccination, suggesting its potential as a highly immunogenic global vaccine.

FRONTIERS IN GENETICS (2021)

Article Medicine, Research & Experimental

SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63

Bezawit A. Woldemeskel et al.

Summary: Recent studies have shown that T cells can cross-recognize spike proteins of SARS-CoV-2 and common cold coronaviruses. Vaccination with SARS-CoV-2 mRNA vaccines results in broad T cell responses to the virus's spike protein, including potential recognition of variant spike proteins. Additionally, post-vaccination, there is an observed increase in CD4(+) T cell responses to certain common cold coronaviruses.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Medicine, Research & Experimental

Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses

Arbor G. Dykema et al.

Summary: Our study confirms the presence of unique memory CD4(+) T cell clones recognizing both SARS-CoV-2 and CCCs. The lower avidity of crossreactive TCRs for SARS-CoV-2 may result in reduced proliferation capacity and impact clinical outcomes in COVID-19 patients. Further research is needed to fully understand the implications of these crossreactive T cell responses.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Biochemical Research Methods

Benchmarking predictions of MHC class I restricted T cell epitopes in a comprehensively studied model system

Sinu Paul et al.

PLoS Computational Biology (2020)

Review Pharmacology & Pharmacy

Coronavirus membrane fusion mechanism offers a potential target for antiviral development

Tiffany Tang et al.

ANTIVIRAL RESEARCH (2020)

Review Biochemistry & Molecular Biology

Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach

Ahmad Abu Turab Naqvi et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)

Article Biochemistry & Molecular Biology

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Takuya Sekine et al.

Article Biochemistry & Molecular Biology

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Carolyn Rydyznski Moderbacher et al.

Article Multidisciplinary Sciences

Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans

Jose Mateus et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Suboptimal SARS-CoV-2-specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype

Jennifer R. Habel et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Biochemistry & Molecular Biology

Age-related rhesus macaque models of COVID-19

Pin Yu et al.

ANIMAL MODELS AND EXPERIMENTAL MEDICINE (2020)

Article Gastroenterology & Hepatology

Hepatitis B virus infection and the immune response: The big questions

Lauke L. Boeijen et al.

BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2017)

Article Gastroenterology & Hepatology

CD8+T-Cell Responses in Hepatitis B and C: The (HLA-) A, B, and C of Hepatitis B and C

Katja Nitschke et al.

DIGESTIVE DISEASES (2016)

Review Immunology

Clinical Relevance of HLA Gene Variants in HBV Infection

Li Wang et al.

JOURNAL OF IMMUNOLOGY RESEARCH (2016)

Review Immunology

The ins and outs of MHC class II-mediated antigen processing and presentation

Paul A. Roche et al.

NATURE REVIEWS IMMUNOLOGY (2015)

Article Biochemistry & Molecular Biology

Association of HLA-alleles with the immune regulation of chronic viral infections

Shokrollah Elahi et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)

Review Multidisciplinary Sciences

Recognition of microorganisms and activation of the immune response

Ruslan Medzhitov

NATURE (2007)